Erythropoietin Improves Muscle Blood Flow in Sepsis
Author Information
Author(s): Kao Raymond, Xenocostas Anargyros, Rui Tao, Yu Pei, Huang Weixiong, Rose James, Martin Claudio M
Primary Institution: University of Western Ontario
Hypothesis
Can recombinant human erythropoietin (rHuEPO) improve skeletal muscle capillary perfusion and tissue oxygenation in sepsis?
Conclusion
rHuEPO treatment leads to increased capillary perfusion and decreased tissue hypoxia in skeletal muscle of septic mice.
Supporting Evidence
- rHuEPO increased perfused capillary density from 28.5 to 33.6 capillaries per millimeter.
- NADH fluorescence decreased from 48.3 to 44.4 FU after rHuEPO treatment.
- Six hours post-treatment, capillary density was higher in rHuEPO treated mice compared to saline.
Takeaway
Erythropoietin helps blood flow in muscles when mice are sick with sepsis, making them feel better.
Methodology
Septic mice received rHuEPO 400 U/kg subcutaneously after surgery, and capillary perfusion and NADH fluorescence were measured using intravital microscopy.
Potential Biases
Potential bias due to the use of a single animal model and the specific conditions of the experiments.
Limitations
The study was conducted in a mouse model, which may not fully represent human sepsis.
Participant Demographics
C57BL/6 mice, ages 10 to 12 weeks, weighing 23 to 26 g.
Statistical Information
P-Value
p < 0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website